Damora Therapeutics, Inc.

DMRA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Jan 7, 2021 FORM 4 SUBMISSION
4 Jan 7, 2021 FORM 4 SUBMISSION
4 Jan 7, 2021 FORM 4 SUBMISSION
4 Jan 7, 2021 FORM 4 SUBMISSION
8-K Jan 5, 2021 8-K
10-Q Dec 11, 2020 10-Q
4 Nov 23, 2020 FORM 4 SUBMISSION
3 Nov 23, 2020 FORM 3 SUBMISSION
8-K Nov 23, 2020 8-K
SC 13G Nov 12, 2020
SC 13G Nov 12, 2020
SC 13D Nov 6, 2020 SCHEDULE 13D
SC 13D Nov 5, 2020 SC 13D
D Nov 5, 2020
4 Nov 4, 2020 FORM 4 SUBMISSION
4 Nov 4, 2020 FORM 4 SUBMISSION
4 Nov 4, 2020 FORM 4 SUBMISSION
4 Nov 4, 2020 FORM 4 SUBMISSION
4 Nov 4, 2020 FORM 4 SUBMISSION
4 Nov 4, 2020 FORM 4 SUBMISSION
4 Nov 4, 2020 FORM 4 SUBMISSION
4 Nov 4, 2020 FORM 4 SUBMISSION
8-K Nov 4, 2020 8-K
S-8 Nov 4, 2020 S-8
424B4 Oct 30, 2020 424B4
← Newer Page 13 of 15 · 352 filings Older →